ONL Therapeutics Advances Global Trial for Vision...
Category : Clinical Trial Update 17 March 2026A key milestone has just been reached in the fight against one of the leading causes of blindness....
Clinical Trial Update
Alzamend Neuro Launches Phase II Trial for Next-Ge...
Category : Clinical Trial Update 17 March 2026A new approach to one of psychiatry’s oldest treatments is now moving into the next stage of c...
Aplagon Doses First Patient in Phase 2a Trial for...
Category : Clinical Trial Update 16 March 2026Clinical-stage biotech Aplagon has reached an important milestone in its pipeline for thrombo-inflam...
Meiji Seika Pharma Begins Phase I Trial of PD-1 Ag...
Category : Clinical Trial Update 16 March 2026Japanese pharmaceutical company Meiji Seika Pharma Co., Ltd. has initiated a Phase I clinical trial...
NIH Awards $2.5M Grant to Amydis to Develop Eye Te...
Category : Clinical Trial Update 14 March 2026Early detection remains one of the biggest challenges in neurodegenerative diseases. Conditions like...
Latest Newsletter Post
-
Alzamend Neuro Launches Phase II Tr..
17 March 2026
-
ONL Therapeutics Advances Global Tr..
17 March 2026
-
Meiji Seika Pharma Begins Phase I T..
16 March 2026
-
Aplagon Doses First Patient in Phas..
16 March 2026
-
NIH Awards $2.5M Grant to Amydis to..
14 March 2026
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com